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About the European Co-operation in 




The European Cooperation in Science and Technology (COST) is the oldest and widest 
European intergovernmental network for cooperation in research. Established by the Ministerial 
Conference in November 1971, COST is presently used by more than 30,000 scientists of 35 
European countries to cooperate in common research projects supported by national funds. The 
financial support for cooperation networks (COST Actions) provided by COST is about 1.5% 
(30 million EUR per year) of the total value of the projects (2,000 million EUR per year). The 
main characteristics of COST are: 
 bottom up approach (the initiative of launching a COST Action comes from the 
European scientists themselves),  
 à la carte participation (only countries interested in the Action participate),  
 equality of access (participation is also open to the scientific communities of countries 
which do not belong to the European Union) and  
 flexible structure (easy implementation and management of the research initiatives).  
 
As a precursor of advanced multidisciplinary research, COST has a very important role in 
shaping the European Research Area (ERA). It anticipates and complements the activities of 
the current Framework Programme for Research and Innovation (Horizon 2020). COST 
activities create a bridge between the scientific communities of countries and increases the 













Welcome from the chairman 
 
 
Welcome to the first Workshop of our COST Action CA16119, that will take place in Tartu, 
the City of Good Thoughts and the second largest city of the country. Tartu is often considered 
the intellectual centre of Estonia, since it is home to the nation's oldest and most renowned 
universities; the University of Tartu and the Estonian University of Life Sciences, which both 
together will host our workshop. 
We will enjoy an exciting scientific day, with outstanding speakers from many different COST 
countries, to discuss about techniques such as 3D cell culture and bioprinting that allow the 
generation of biologically relevant tissue models for different applications. I do hope this first 
workshop will encourage many collaborations in the field, and will further implement synergies 
and networking within the Action participants.  
I would like to thank Ülle Jaakma and all the other members of the local organizing committee 
for the fantastic work they have done in organizing this event. Also many thanks to our WG1 
Leaders for their input in composing the program and to Shaghayegh Basatvat for managing 
the technical aspects. 
Aitäh külalislahkuse eest! 
Prof Tiziana A.L. Brevini 
Chair of CellFit 











Welcome address from working group 1 
leaders 
 
Dear CellFit Members 
 
Welcome to the first Workshop of our COST Action CA16119 that will focus on the activities 
of the 3-D culture technology and bioprinting Work Group. The creation of tissue-like 
constructs in vitro requires the development and application of new approaches. At this 
Workshop, we will hear from leading researchers developing some of the latest innovative 
technologies to enhance the structure and function of cultured cells. Attendees will learn about 
techniques such as 3D cell culture and bioprinting that allow the generation of biologically 
relevant tissue models for different applications. 
We present a programme of excellent speakers from the fields of 3D cell culture and bioprinting 
and look forward to fruitful discussions, networking, and the development of collaborations to 
make new advances in this exciting field of research. 
 
Kind regards, 
Prof Stefan Przyborski (WG 1 leader) 















Welcome address from the local 
organiser 
 
Dear CellFit members, 
 
Welcome to Tartu, the university town and intellectual centre of Estonia. We believe in the very 
special “Spirit of Tartu“ that inspires not only citizens but  also our guests. The spirit of Tartu 
is embedded in the Old Town cobblestones, carved into the historic buildings and appears often 
around the students, university buildings and numerous scientific or cultural events.  
Tartu has been a university town and a city for young people for a long time. The University of 
Tartu – Estonia’s largest university – was established in 1632. The Veterinary Institute as a 
predecessor of the Estonian University of Life Sciences, was founded in 1848. 
The city has been renowned as a centre of expertise in medical and veterinary research, and 
health technologies. We are excited about the opportunity to host the workshop of the COST 
Action CA16119 CellFit on bioprinting and 3D cell culture. This event will bring us new 
knowledge on how to create synergy between bio-engineering and clinical research. I believe 
that this event will strengthen the collaboration between the researchers of different countries 
and inspires young scientists. 
Tere tulemast! Welcome! 
 
Ülle Jaakma 
Vice-Rector of Research 








Welcome address from the Intercellular 
Epigenomics scientific committee 
 
Dear participants of the “Intercellular Epigenomics” Meeting 
Please accept our very warm welcome and thanks for participating in this meeting.  
As you all know, intercellular communication is a general term used in physiology and 
medicine to characterize different means of communication between living cells. Cells need to 
communicate with each other to survive and accomplish their tasks. They use different means 
of communication and utilize different chemicals and factors. A comprehensive collection of 
literature exists that describe in detail these compounds and the role that each may play in 
mediating intercellular communication.  
In recent years, a new paradigm has come to the fore, pointing to the role that the transfer of 
nucleic acids, and in particular different forms of non-coding RNA, may play in the concept of 
cell-cell communication. There are several examples that cells transfer/exchange genetic 
messages with each other in the context of both maintaining health and disease pathogenesis.  
For this meeting, we aimed to gather lectures/experts to illustrate different examples of cell-to-
cell communication that potentially are involved with the transfer of genomic materials from 
one cell to another cell, with effects on cellular function and the health of an individual. We 
thought the best approach to understand how this phenomenon is regulated and what the current 
gaps in knowledge are, was to gather people from different fields studying this subject under 
one roof together and hearing their experiences. We are very grateful to all the lecturers for 
accepting our invitation to come to Tartu. We look forward to a very fruitful day with lots 
insightful and lively discussion. 
In organising this meeting we took advantage of the help and advice of many colleagues and 
friends. In particular, we would like to mention Olivika Zeiger, Marie Reeman, Shaghayegh 
Basatvat and Publicon crew for their help and professional service that made this meeting a 
reality.  
Scientific organizing committee of “Intercellular Epigenomics” meeting 




Programme on April 10th , 2018 (arranged 
by CellFit cost action 16119) 
 
07:00-08:30 Breakfast for those accommodated at the VSpa Hotel 
08:30 Ordered buses leaving from the VSpa Hotel to the University of Life Sciences 
08:00-09:00 The registration desk is open at the University of Life Sciences 
09:00-09:15 (15:00) Welcome address and introduction (Prof. Stefan Przyborski, Durham 
University, United Kingdom) 
 Theme 1: 3D Cell Culture Models 
09:15-09:55 (40:00)          Clinostat based spheroid cultures - recovery of physiological functions     
through self-assembly of mimetic tissue structures. (Dr. Krzysztof 
Wrzesinski, CelVivo IVS, Denmark) 
09:55-10:10 (15:00) 3D strategies for improving hnMSC derived hepatocyte-like cells (HLCs) for 
in vitro toxicology applications. (Dr. Joana P. Miranda, University of Lisbon, 
Portugal) selected from abstracts 
10:10-10:25 (15:00) The application of 3D cell model for genotoxicity testing. (Prof. Bojana 
Zegura, National Institute of Biology, Slovenia) selected from abstracts 
10:25-11:00 (35:00) Coffee break and Poster presentation  
11:00-11:40 (40:00)          The extracellular environment of cells and how we can get them to build it 
in vitro. (Prof. Michael Raghunath, Zurich University of Applied Sciences, 
Switzerland) 
11:40-11:55 (15:00)          Animal-derived versus recombinant photo-cross linkable hydrogels for  
                                           Adipose tissue engineering (Liesbeth Tytgat, University of Vrije, Belgium)  
                                          Selected from abstracts 
 
11:55-14:15 (140:00)        Lunch 
 Theme 2: Bioprinting and Biofabrication 
14:15-14:45 (30:00) COST Rules of Travel reimbursement 
14:45-15:25 (40:00)          Challenges and Promises of Cartilage bioprinting. (Prof. Marcy Zenobi-
Wong, ETH Zurich, Switzerland) 
15:25-16:05 (40:00)           Engineering skeletal muscle tissue with innovative 3D bioprinting 
approaches. (Dr. Marco Costantini, Campus Bio-Medico University of Rome, 
Italy) 
16:05-16:45 (40:00) Coffee break        
16:45-17:25 (40:00)          Improving in vitro models of cancer using 3D bioprinting. (Prof. Nicholas R. 




17:25-17:45 (20:00)           Wrap up, discussion 
19:30-22:00 Gala Dinner at Joyce Restaurant  
 
Programme on April 11th , 2018 (operated 
by Searmet and transgeno) 
 
07:00-08:00 Breakfast at the VSpa Hotel (afterwards transfer to University of Life 
Sciences) 
08:00-09:00  Registration desk open (University of Life Sciences) 
09:00-09:15 (15:00) Welcome address and introduction (Prof. Alireza Fazeli and Prof. Ülle Jaakma) 
 Theme 3: Intracellular Epigenomics 
09:15-09:55 (40:00)          Role of exosomal microRNAs in the biology of the Tumor Microenvironment 
(Dr Muller Fabbri, University of Southern California, USA) 
09:55-10:35 (40:00) The message of a heart beat: cardiomyocyte communication in apical   
                                            hypertrophic cardiomyopathy (Dr James Smith, University of Nottingham,  
                                            UK) 
10:35-11:00 (25:00) Coffee break and Poster presentation  
11:00-11:40 (40:00)          The role of small nucleolar RNAs in osteoarthritis. (Dr. Mandy Peffers, 
University of Liverpool, UK) 
11:40-12:00 (20:00)          Effect of maternal Insulin-dependent diabetes and hormonal stimuli on 
                                           embryonic microRNA expression. (Anne Navarrete Santos, Martin Luther  
                                           University, Germany) selected talk from abstracts               
12:00-12:20 (20:00)         Identification of Extracellular vesicle’s RNA profile, during trophoblast and     
                                          Endometrial cellular communication. (Masoumeh Eshaghi, University of   
                                          Tartu, Estonia) selected talk from abstracts                
12:20-14:00 (100:00)        Lunch  
14:00-14:40 (40:00)          Extracellular Vesicle Communication in Cancer and other complex diseases. 
(Dr Vicky James, University of Nottingham, UK) 
14:40-15:20 (40:00)         Extracellular vesicles-associated RNA-protein complexes as carriers of                                                
                             epigenetic information Prof. Italia Di Liegro, University of Palermo, Italy.  
15:20-15:40 (20:00) Coffee break 
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15:40-16:20 (40:00)          Extracellular vesicles in the host-parasite communication. (Prof. Antonio 
Marcilla, University of Valencia, Spain) 
 
16:20-17:00 (40:00)         Extracellular vesicles released from the commensal yeast Malassezia  
                                          sympodialis – host-microbe interactions (Prof. Annika Scheynius, Karolinska  
                                           Institutet, Sweden) 
17:00-17:20 (20:00)           Wrap up, discussion 
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Clinostat based spheroid cultures - recovery of 




Krzysztof Wrzesinski a, Stephen J. Fey a, Carlemi Calitz b, Adelina Rogowska-Wrzesinska c,  
a CelVivo IVS, Odense, Denmark; b North-West University, Potchefstroom, South Africa; 
c University of Southern Denmark, Odense, Denmark 
 
Cells grown as active 3D spheroid/ organoid 
cultures have physiological performances that 
mimic that seen in human tissues better than 
cells grown in 2D culture. Cells grown in 2D or 
in 3D represent two ‘extremes’ of cellular 
programming (the cultural divide). At one 
extreme is exponential growth with diminished 
functionality (as seen in wound healing or 
cancer, and experimentally in traditional 2D 
cultures) and at the other extreme is a dynamic 
equilibrium with very slowly proliferating cells 
with a highly specialized functionality (as seen in tissues and experimentally as cells grown as 
active 3D spheroids) fig 1. We have shown that the hepatocellular carcinoma cells HepG2/C3A 
grown as active 3D spheroid cultures for periods longer than 18 days have physiological 
performances that mimic that seen in human tissues better than identical cells grown in 2D 
culture.  
Proteome and cellular architecture at these two extremes are dramatically different. 
Metabolically, glycolysis, fatty acid metabolism and the pentose phosphate cycle are increased 
while Krebs cycle and oxidative phosphorylation is unchanged. Enzymes involved in 
cholesterol and urea synthesis are increased underpinning the attainment of cholesterol and urea 
14 
 
production rates seen in vivo. DNA repair enzymes are increased. There are numerous coherent 
changes in transcription, splicing, translation, protein transport, folding and degradation. The 
amount of individual proteins within complexes is shown to be highly coordinated. Typically, 
subunits which initiate a particular function are present in increased amounts compared to other 
subunits of the same complex. 
Conclusion: 3D spheroids offer a window into in vivo physiology! 
REF: K. Wrzesinski and S.J. Fey. 2018. Metabolic reprogramming and the recovery of 
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3D strategies for improving hnMSC derived hepatocyte-
like cells (HLCs) for in vitro toxicology applications 
 
 
Joana P Miranda, iMed.ULisboa/Faculty of Pharmacy, Universidade de Lisboa 
Lisboa; Madalena Cipriano, iMed.ULisboa/Faculty of Pharmacy, Universidade de Lisboa; 
Nora Freyer, iMed.ULisboa/Faculty of Pharmacy, Universidade de Lisboa; Knoespel F., 
Bioreactor Group, Berlin Brandenburg Center for Regenerative Therapies (BCRT), Charité 
Universitätsmedizin Berlin, Berlin, Germany; Santos J.M., CECA/ICETA, University of 
Oporto, Oporto, Portugal; Oliveira N.G., Research Institute for Medicines (iMed.ULisboa), 
Faculty of Pharmacy, Universidade de Lisboa. Lisbon, Portugal; Zeilinger K. Bioreactor 
Group, Berlin Brandenburg Center for Regenerative Therapies (BCRT), Charité 
Universitätsmedizin Berlin, Berlin, Germany 
jmiranda@ff.ul.pt 
 
Human-relevant data on hepatic drug metabolism and toxicity can only be generated with cell 
systems that exhibit all liver-specific functions. We have been focusing our studies on deriving 
functional hepatocyte-like cells (HLCs) from human neonatal mesenchymal stem cells 
(hnMSCs) by optimizing the differentiation procedure, namely with exposure to epigenetic 
markers, and by resorting to more physiological-like 3D-models. Global transcriptional 
analyses of the HLCs at day 34 showed a partial hepatic differentiation degree revealing shared 
expression of gene groups between HLCs and hpHeps (human primary hepatocytes). In 
addition, bioinformatics analysis of gene expression data placed HLCs between the HepG2 and 
hpHeps and distant from hnMSCs. The enhanced hepatic differentiation observed was 
supported by the presence of the hepatic drug transporters OATP-C and MRP-2 and gene 
expression of the hepatic markers CK18, TAT, AFP, ALB, HNF4A and CEBPA; and by their 
ability to display stable UGTs, EROD, ECOD, CYP1A1, CYP2C9 and CYP3A4-dependent 
activities. In addition, HLCs differentiation was attempted using self-assembled spheroids or 
multi-compartment membrane bioreactor models. Overall, the 3D-systems improved the liver 
16 
 
specific phenotype, although the differences between phenotypic impacts promoted by each 
model are enough to entail that optimal culture systems should be selected depending on the 
scientific applications. Our findings suggest a role of the epigenetic modifiers in hepatic 
differentiation and maturation and reinforce the importance of the cell culture environment as 
a key factor for the maintenance of the hepatocyte-like phenotype. Finally, this work supports 
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The application of 3D cell model for genotoxicity testing  
 
Martina Stampar, Department of Genetic Toxicology and Cancer Biology, National Institute 
of Biology, Vecna pot 111, 1000 Ljubljana, Slovenia; Bojana Zegura, Department of Genetic 
Toxicology and Cancer Biology, National Institute of Biology, Slovenia; Metka Filipic, 
Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, 
Slovenia; Jana Tomc, Department of Genetic Toxicology and Cancer Biology, National 
Institute of Biology, Slovenia 
martina.stampar@nib.si 
 
Genetic toxicology plays an essential role within hazard identification and risk assessment 
during the development of novel drugs, as well as chemicals, cosmetic products, food and feed 
additives, pesticides, herbicides and others. Throughout the early stage of drug development, a 
substance’s ability to damage DNA through genotoxic mechanisms must be fully investigated 
to enable accurate and cost-effective hazard and risk assessment. For this purpose, two-
dimensional (2D) cell cultures are used in the first stage of drug development before moving to 
in vivo experiments. However, 2D models have several limitations, such as the lack of 
metabolic activity. They express low levels of phase I (activation) and phase II (detoxification) 
metabolic enzymes required for metabolic activation of indirect acting genotoxic compounds. 
Therefore, it is very important and essential to develop improved in vitro cell-based systems 
that can more realistically mimic the in vivo cell behaviors and provide more predictive results 
to in vivo conditions. The three-dimensional (3D) models have improved cell-cell and cell-
matrix interactions and have preserved complex in vivo cell phenotypes. Moreover, 3D hepatic 
models exhibit higher levels of liver-specific functions including metabolic enzymes compared 
to 2D models. Therefore, the aim of our study was to develop 3D cell model from human 
hepatoma (HepG2) cell line and to validate the model using indirect-acting model genotoxic 
compound, polycyclic aromatic hydrocarbon benzo(a)pyrene (BaP) that needs metabolic 
activation for its genotoxic activity. In three days old spheroids non-cytotoxic concentrations 
of BaP (10, 20 and 40 µM) after 24 hours of exposure induced dose dependent increase in the 
formation of DNA strand breaks determined with the comet assay. Furthermore, the 
transcriptomic analyses (qPCR) revealed that HepG2 cells in 3D model express important genes 
18 
 
of enzymes involved in phase I (CYP1A2, CYP1A1, CYP3A4) and II (UGT1A1, SULT1A1, 
NAT1, NAT2) metabolism, as well as DNA damage responsive genes (P53, GADD45α, 
CDKN1A) at mRNA level. The results were confirmed at the protein level (Western blot). 
Altogether, the study showed that newly developed in vitro 3D model has improved metabolic 
capacity and can be used for genotoxicity assessment. Nevertheless, the 3D model has to be 
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The extracellular environment of cells and how we can get 
them to build it in vitro  
 
Nicole Kohli, Michael Raghunath, Zurich University of Applied Sciences (ZHAW), 8820 
Wädenswil, Switzerland 
 
The overarching principle of 3D Bioprinting is the placing of cells or cell clusters in three-
dimensional space to generate cohesive tissue microarchitecture. The most popular technique 
is to deliver cells in so-called bioinks that contains them during the printing process and ensures 
shape fidelity of the printed structure. Whatever the technique, the central question in 
bioprinting is what happens after the printing process? Will constructs collapse, will cells 
remodel the pre-existing scaffold, will they die or proliferate, and will they migrate and 
differentiate towards a mature state of the construct. The key to this lies in the formation of an 
intrinsic extracellular matrix (ECM) by the cells. We have been developing macromolecular 
crowding (MMC) to accelerate ECM deposition by a variety of cells in monolayer culture. As 
bioinks essentially are hydrogels, we hypothesized that cells embedded and differentiated in 
hydrogels would still benefit from MMC. We embedded human bone marrow-derived 
mesenchymal stromal cells (MSCs) in collagen hydrogel (1mgmg/ml) and studied adipogenic 
differentiation and extracellular matrix deposition under MMC. As in monolayer culture, MSCs 
under MMC deposited more ECM, and when differentiated to adipocytes formed a collagen IV 
cocoon around them. Moreover, some cocoons seem to connect via ECM-bridges. These 
findings suggest that hydrogels indeed are amenable to MMC and that it is possible to tune 
deposition and microarchitecture of intrinsically produced ECM inside them. This opens up 
opportunities to manipulate bio-ink-based bioprinting systems, including scaffold-free 
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Animal-derived versus recombinant photo-crosslinkable 
hydrogels for adipose tissue engineering  
 
Liesbeth Tytgat, Vrije Universiteit Brussel, Belgium; Marica Markovic, Institute of Materials 
Science and Technology, Technische Universität Wien, Austria; Heidi Ottevaere, Brussels 
Photonics, Vrije Universiteit Brussel, Belgium; Hugo Thienpont, Brussels Photonics, Vrije 
Universiteit Brussel, Belgium; Aleksandr Ovsianikov, Institute of Materials Science and 
Technology, Technische Universität Wien, Austria; Peter Dubruel, Polymer Chemistry & 
Biomaterials Group, Centre of Macromolecular Chemistry (CMaC), Ghent University, 
Belgium; Sandra Van Vlierberghe, Polymer Chemistry & Biomaterials Group, Centre of 




Animal-derived gelatin-based materials are frequently used for various tissue engineering 
applications due to their excellent cell-interactive characteristics. However, the concerns 
associated with the use of animal-derived materials have emerged due to batch to batch 
variations and the risk of pathogen transmittance. We hypothesize that recombinant collagen I 
peptide (RCP) (CellnestTM, Fujifilm) could be a promising alternative to solve the issues 
associated with gelatin from animal origin. 
EXPERIMENTAL METHODS 
Gelatin B and RCP were modified using 2.5 and 1 equivalents methacrylic anhydride (MA) 
(GEL-MOD with a degree of substitution (DS) of 97% and RCP-MOD with a DS of 90%). The 
materials were characterized in depth via (HR-MAS) 1H-NMR spectroscopy, rheology, 
swelling and gel fraction experiments. The biocompatibility of the hydrogels was evaluated by 
monitoring the metabolic activity of encapsulated ASC-TERT cells. 3D scaffolds were 
fabricated via two-photon polymerization (2PP). 
RESULTS AND DISCUSSION 
RCP-MOD contained 1.6 times more photo-crosslinkable groups compared to GEL-MOD. The 
DSC results showed that the physical crosslinking behavior of RCP-MOD was hampered due 
to the higher number of double bonds. The gel fraction and HR-MAS results indicated an 
21 
 
efficient crosslinking for both materials. The storage modulus of RCP-MOD was comparable 
with GEL-MOD (6 kPa). The swelling properties of RCP-MOD was lower compared to GEL-
MOD, which was anticipated since RCP-MOD has 20% more hydrophobic and 24% less 
hydrophilic moieties than GEL-MOD. The cell tests and literature reports indicated that RCP-
MOD and GEL-MOD respectively are biocompatible. RCP-MOD and GEL-MOD could be 
processed via 2PP into 3D scaffolds.  
CONCLUSIONS  
The physico-chemical properties, the biocompatibility and the processing potential of RCP-
MOD are comparable with those of GEL-MOD indicating that RCP-MOD is an attractive 
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Challenges and Promises of Cartilage Bioprinting 
 
Marcy Zenobi-Wong, ETH Zürich, Zürich, Switzerland  
  
Bioprinting combines cells, biological materials and biopolymers as building blocks to fabricate 
tissues for use in regenerative medicine.  Bioprinting’s great promise is to deliver tissue 
replacement grafts which are personalized in terms of geometry, material properties and the 
patient’s own cells.   
First generation printing materials were made from relatively inert and soft biomaterials, 
limiting their performance in in vivo weight-bearing applications.  Since cells of the body 
reside in an extracellular matrix (ECM) rich in biological and biophysical signaling 
information, there is an increasing interest in identifying key features of the native ECM 
which are critical to tissue development and incorporating these into the so called ‘bioinks’ 
used in bioprinting.     
New generations of bioinks increase the biological activity and mechanical strength of printed 
tissues.  Using cartilage as a model tissue, our laboratory focuses on the incorporation of 
biological signals which promote cell proliferation and matrix deposition via growth factor 
binding affinity.  We also develop nanocomposite printable materials to increase strength of the 
constructs. Together, these approaches take us steps closer to fabricating bioprinted tissue 




1. Kesti, M, C. Eberhardt, Pagliccia, G, Grande, D, Boss, D, Zenobi-Wong, M*, 
Bioprinting complex cartilaginous structures with clinically-compliant biomaterials, 
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Engineering skeletal muscle tissue with innovative 3D 
bioprinting approaches 
 
Marco Costantini1, Jan Guzowski1, Wojciech Święszkowski2, Cesare Gargioli3 
1Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland. 
2Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw, Poland 
3Department of Biology, University of Rome Tor Vergata, Rome, Italy 
 
Abstract 
Within the human body, skeletal muscle (SM) tissue is responsible for a multitude of 
fundamental functions. All voluntary movements that characterize our lives, from a single step 
to a simple smile, would not be possible without this highly specialized tissue. In the last two 
decades, driven by its limited regenerative capacity, researchers have developed numerous 
approaches to restore/repair SM tissue. However, the obtained results are still far from being 
satisfactory.  
 
Here, we present a new strategy for the 
fabrication of artificial myo-structures with 
functional morphologies based on an 
innovative 3D bioprinting approach.[1] The 
core of this system is a microfluidic printing 
head coupled with a co-axial nozzle extruding 
system that allows high-resolution 3D multi-
cellular bioprinting of hydrogel fibers (Ø ≈ 100 µm) and high cell viability. To promote 
myoblast differentiation, we formulated a tailored bioink with a photocurable semi-synthetic 
biopolymer, namely PEGylated fibrinogen, and we encapsulate cells (C2C12 or human 
pericyte) in 3D scaffolds composed of unidirectionally aligned hydrogel fibers. The 3D 
fabricated samples were tested both in vitro and in vivo to evaluate their capability of supporting 
myogenesis and sarcomerogenesis. The results showed that after 21 days of culture in vitro, 
24 
 
myoblasts properly spread and fused forming highly aligned long-range multinucleated 
myotubes, with abundant and functional expression of myosin heavy chain and laminin. 
Besides, 3D biofabricated constructs when grafted in vivo led to a substantial improvement if 
compared to bulk-hydrogels (used as control) of muscle-like architectural organization with the 
formation of tightly-packed, highly parallel and completely striated myotube fibers. 
 
References 
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Improving in vitro models of cancer using 3D Bioprinting 
Nicholas R Leslie 
Heriot Watt University, Edinburgh, UK 
 
In-vitro brain tumour models are valuable tools both to study cancer biology and for successful 
pre-clinical testing of anticancer drugs. However, substantial challenges remain before we can 
create physiologically-relevant models which closely mimic the microenvironment of human 
brain tumours and reveal their response to therapies. We have developed a 3D bioprinting 
strategy using modified alginate matrices incorporating hyaluronan and collagen, in order to 
create tumour-like structures containing both glioma stem cell lines and glioma derived stromal 
cells. Our results to date show that the printing process can be performed with minimal effects 
on cell viability, even when cells are printed at high density; that cells proliferate after printing 
and that rapid cell-cell adhesion can be promoted with appropriate matrices. We are able to 
print glioma stem cells with and without stromal cells in separate layers within tumour like 3D 
constructs with a smallest feature size (resolution) of approximately 300m. This capability to 
spatially position cell populations and other components within a 3D tumour construct allows 
new experimental approaches by controlling individual parameters of the tumour 
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Role of exosomal microRNAs in the biology of the Tumor 
Microenvironment 
 
Muller Fabbri, MD, PhD, Children’s Hospital Los Angeles- University of Southern 
California, Los Angeles, CA, USA 
 
Extracellular vesicles (EVs) mediate inter-cellular communication among different cell 
populations of the Tumor Microenvironment. Exosomes are a subtype of EVs that carries a 
cargo of different types of functional macromolecules, including microRNAs (miRNAs) and 
other coding and non-coding RNAs. We have identified a new paracrine function of exosomal 
miRNAs within the Tumor Microenvironment. Cancer cells release specific miRNAs within 
exosomes, and this miRNAs are successfully uptaken by surrounding immune cells. We 
describe a “hormone-like” mechanism of miRNA binding to Toll-like receptor 8 in immune 
cells, triggering a pro-tumoral inflammatory response responsible for increased tumor growth 
and resistance to chemotherapy. We will also discuss how exosomal miRNAs derived from 
immune cells can elicit anti-tumoral effects and how these discoveries can be exploited for the 
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The message of a heart beat: cardiomyocyte 
communication in apical hypertrophic cardiomyopathy 
 
James Smith, Victoria James and Chris Denning 
University of Nottingham, Nottingham, United Kingdom  
 
Hypertrophic cardiomyopathy (HCM) is a thickening of the ventricles that can lead to 
devastating conditions such as heart failure and sudden cardiac death. HCM is linked to 
mutations in genes encoding cardiac sarcomeric proteins, such as ACTC1 encoding for actin. 
Despite extensive study the mechanisms mediating many of the associated clinical 
manifestations, such as interstitial fibrosis, remain unknown and human models are required. 
To address this, hiPSC lines were generated from heart patients with a HCM associated ACTC1 
mutation (E99K). Isogenic controls were created for each line by correcting the mutation using 
CRISPR/Cas9 gene editing technology. Isogenic pairs were differentiated to cardiomyocytes 
and subjected to electrical stimulation to capture the cells at a stress-inducing 3Hz contraction 
frequency. Following 24 hours pacing, conditioned medium was collected and exosomes 
isolated and characterised. The pattern of release (size and quantity) of exosomes produced by 
diseased cardiomyocytes was significantly altered compared to isogenic control lines. Stressed 
conditioned medium, containing exosomes, was shown to activate fibroblasts into a more 
secretory active myofibroblast state. We hypothesise that E99K mutant cardiomyocytes modify 
the release and content of their extracellular vesicles, and are investigating whether this causes 
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Small nucleolar RNAs in osteoarthritis  
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Small nucleolar  RNAs (snoRNAs) are non-coding RNAs of 50-150 nucleotides long with a 
main task in post-transcriptional modification of ribosomal RNAs (rRNAs). A small subset of 
snoRNAs (eg U3), function in endoribonucleolytic processing of 47S pre-rRNA. We are 
currently undertaking a number of targeted and discovery studies to investigate the relevance 
of snoRNAs for osteoarthritis (OA) progression, cartilage ageing and OA biomarker discovery. 
General chondrocyte molecular biology methods were used to isolate, culture and analyse 
chondrocytes, cartilage and serum/synovial fluid. Transcriptomics was performed using micro-
array and RNAseq. Intervention with snoRNA expressions was performed by transfecting anti-
sense oligonucleotides. 
Ageing and OA development led to alterations of specific snoRNA expression in whole mouse 
joints. Micro-array expression profiling of young, old-protected and old-OA human cartilage 
demonstrated age-specific and OA-specific expression of snoRNAs. Indeed we have evidence 
that alterations in U3 snoRNA expression leads to OA-like changes in the chondrocyte 
phenotype and that U3 can be influenced by morphogens and cytokines. Also knock-down of 
OA-specific snoRNAs induces changes in chondrocyte differentiation status and rRNA levels. 
Our biomarker studies have identified ageing- and OA-specific expression of snoRNAs. We 
are now exploring the snoRNA content of healthy and OA synovial fluid to identify snoRNA 
biomarkers for early OA development and investigate whether synovial fluid-mediated inter-
tissue communication within the joint involves snoRNAs. 
Our data show for the first time that specific snoRNAs are differentially expressed in ageing- 
and OA cartilage. SnoRNAs provide an unexplored class of non-coding RNAs relevant for 
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Placenta-specific microRNAs (miRs) represent a new class of biological markers for prenatal 
diagnosis as they reflect physiological and pathological placental conditions. Placenta 
development starts as early as during blastocyst development with embryoblast and trophoblast 
differentiation. We hypothesise that specific trophoblast miRs could be a useful tool for the 
identification of diabetes-related placental dysfunction. Therefore, we have analysed the 
influence of a maternal type 1 diabetes mellitus on miR expression in vivo in maternal blood 
plasma and endometrium as well as in the preimplantation embryo, using the rabbit as 
experimental model. Further, in in vitro embryo culture we examined direct effects of insulin, 
glucose, IGF2 and LIF on embryonic miR expression. 
Maternal diabetes led to a downregulation of miR-27b, -141, -191 and -222 in maternal plasma 
and endometrium and in embryonic samples (embryoblast and trophoblast cells). These miRs 
were also present in the blastocyst cavity fluid, but were not affected by maternal diabetes. 
Furthermore, we detected an altered mRNA expression of miR target genes in blastocysts 
developed under diabetic conditions. In in vitro experiments LIF, insulin, IGF2 and glucose 
30 
 
were capable to stimulate embryonic miR-27b, -141, -191 and -222. 
In vitro data indicate that changes in maternal hormones and metabolites regulate embryonic 
miR expression with potentially consequences for blastocyst development and implantation. 
Furthermore, the altered miR expression in both embryonic compartments and in maternal 
plasma during diabetic pregnancy demonstrates that miRs could serve as biological markers as 
early as during the preimplantation period.  
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Extracellular vesicles (EV) could be a mean for maternal and embryonic cell lines 
communication. This study has aimed to identify the RNA profile of extracellular vesicles that 
exchanged between trophoblast and endometrial cells during communication. 
The 5-Ethynyl uridine (EU) labeled trophoblast spheroids were cultivated with an endometrial 
cell line in a non-contact co-culture system. The trophoblast EU-labeled RNA was tracked and 
captured in endometrial cells. The transferred labeled RNA, was affinity-precipitated and 
purified using biotin-azide click chemistry. Total RNA-sequencing was conducted with 
synthesized cDNA from captured labeled and non-EU labeled RNA (background) (n=4). 
Differential expression analysis of RNA-seq data was performed using edgeR and limma 
packages to identify the transferred transcripts using differential enrichment as a proxy. The 
Integrative Genomics Viewer was used to validate the coverage of differentially enriched 
transcripts. The results were confirmed by Quantitative PCR (qPCR). To establish the route of 
candidate RNA transfer, EVs were isolated from co-culture media using size exclusion 
chromatography. Total RNA was extracted from EVs, EU-labeled RNA was affinity-
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precipitated and the absolute copy number of putatively transferred RNA sequences was 
quantified.  
Differential enrichment analysis demonstrated that the majority of putatively transferred 
transcripts were non-coding RNAs derived from the mir99alet7c cluster (Chromosome 21: 
LINC00478). The presence of non-coding sequences from this chromosomal region in the RNA 
extracted from EVs was confirmed by qPCR. This suggest that these sequences are carried by 
throphoblast EVs.  
In this study we showed that bioortogonal RNA labeling chemistry can be used for the 
deciphering trophoblast-endometrial communications. These are the initial steps towards 
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The role of extracellular vesicles (EVs) as vehicles for cell-to-cell communication between a 
tumour and its environment is a relatively new concept. However, the hypothesis that EVs may 
play a critical role in co-opting tissues by tumours to generate a metastatic niche is generating 
significant interest. Using prostate cancer as a model, we demonstrated the potential role of EVs 
as a mechanism of mediating prostate cancer to bone metastasis, and specifically the 
contribution of the EV-RNA cargo as a means of communication between prostate cancer cells 
and cells of the bone stroma.  
We demonstrate the effect of prostate cancer cell EVs on osteoblast proliferation and apoptosis, 
and how exposing osteoblasts to prostate cancer EVs creates a significantly more supportive 
growth environment for prostate cancer cells when grown in co-culture (p<0.005). 
Characterisation of the RNA cargo of EVs produced by the bone metastatic prostate cancer cell 
line PC3, highlights that the EV-RNA cargo is significantly enriched in genes relating to cell 
surface signalling, cell-cell interaction, and protein translation (p<0.01). Using techniques to 
track RNA originating from the prostate cancer cell, we demonstrate the delivery of a set of 
prostate cancer originating RNAs to osteoblast via prostate cancer EVs and show the effect on 
osteoblast endogenous transcript abundance. Together, this work advances our understanding 
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of EV function in cancer and beyond by highlighting the contribution of the RNA element of 
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Background: Cancer cells are much more active than normal cells in producing different kinds 
of extracellular vesicles (EVs), through which they transfer to the surroundings transforming 
nucleic acids and proteins [1]. We previously found that EVs released from G26/24 
oligodendroglioma cells can transfer, via EVs, various proteins, among which pro-apoptotic 
factors [2], extracellular matrix remodeling proteases (such as ADAMTS) [3], and the H1.0 
histone protein [4]. Similarly, A375 melanoma cells release EVs containing a sumoylated form 
of  H1.0, as well as H1.0 RNA [5].  
Aim: To investigate the possibility that EVs contain specific RNA-protein complexes with the 
potential to induce epigenetic modifications in recipient cells.  
Methods: EVs were purified from A375 melanoma cells. Protein extracts from both cells and 
EVs were used for T1 RNase-protection assays, using as target the H1.0 RNA. In a second step, 
we used affinity chromatography on a biotinylated H1.0 RNA to fish H1.0 RNA-binding 
proteins, to be finally identified by mass spectrometry. 
Results: Three main complexes were evidenced, the most abundant of which had an apparent 
molecular mass of about 65 kDa. In the second step, we identified myelin expression factor-2 
(MYEF2) as a major H1.0 mRNA-binding protein in EVs released from melanoma cells [5].  
Conclusion: MYEF2 was already known as a transcription factor with putative RNA-binding 
domains. Our demonstration of its actual ability to bind RNA rises the interesting possibility 





[1] Schiera G, et al. 2015.Biomed Res Int. 2015:152926; [2] Lo Cicero A et al. 2011, Int J Oncol 
39:1353-7; [3] Lo Cicero A et al. 2012, Matrix Biol 31:229-33; [4] Schiera G et al. 2013, Int J 
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Extracellular vesicles in the host-parasite communication  
 
Marcilla, A., Galiano, A., Sánchez, C.M., Cifre, S., Cantalapiedra, F., Trelis, M., Bernal, D. 
Universitat de València, Burjassot (Valencia), Spain  
 
Parasitic diseases are a major public health issue, with billions of people infected mainly in 
poor regions, and some of them are considered as neglected tropical diseases (1). Parasites have 
evolved complex life cycles involving different hosts provoking a wide range of clinical 
outcomes from asymptomatic to severe infections, including death (2). The host-parasite 
interaction require refined pathogen-specific intercellular communications, where extracellular 
vesicles seem to play a pivotal role (3, 4). Extracellular vesicles are well recognized as 
mediators of intercellular communications in prokaryotes and eukaryotes, transferring 
functional information to recipient cells that signal normal and pathophysiological processes 
(5). Since these vesicles contain pathogen-derived molecules, they represent novel approaches 
for identifying biomarkers of disease, as well as new antigens for vaccination (5).  
We will discuss our experience in the isolation and characterization of parasite extracellular 
vesicles, as well as their possible applications in controlling parasitic diseases, as new 
diagnostic tools (biomarkers) and their usefulness in vaccination assays. Along with parasitic 
diseases, we will also address their usefulness in treating autoimmune diseases. 
References: 
1. http://www.who.int/neglected_diseases/diseases/en/ 
2. Cox (2002). Clin Microbiol Rev. 15:595–612 
3. Marcilla et al., 2014. J Extracell Vesicles 3:25040 
4. Schorey & Harding (2016). J Clin Invest. 126:1181–89. 
5. Yañez-Mo et al. (2015).  J Extracell Vesicles. 4:27066. 
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Extracellular vesicles released from the commensal yeast 
Malassezia sympodialis – host-microbe interactions  
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Malassezia is a dominant commensal fungi in the human skin mycobiome but is also associated 
with common skin disorders including atopic eczema (AE). More than 50 % of AE-patients 
have specific IgE and T-cell reactivity towards Malassezia sympodialis, which is one of the 
most frequently isolated species from both AE patients and healthy individuals. We have found 
that M. sympodialis releases extracellular nanovesicles, designated MalaEx, which are carriers 
of allergens and can induce inflammatory cytokine responses. To further elucidate M. 
sympodialis host-microbe interactions we assessed whether small RNAs are present in MalaEx 
and could identify a set of reads in a length range of 16 to 22 nucleotides. Interestingly, these 
RNA features appear to have an RNAi-independent route for biogenesis. We further compared 
the protein content of MalaEx with that of the parental yeast cells. iTRAQ based quantitative 
proteomics identified in total 2439 proteins in all replicates of which 110 were enriched in 
MalaEx compared to the yeast cells. Among the MalaEx enriched proteins were two of the 
major M. sympodialis allergens, Mala s 1 and s 7. Functional experiments indicated an active 
binding and internalization of MalaEx into human keratinocytes and monocytes, and MalaEx 
were found in close proximity of the nuclei using super-resolution fluorescence 3D-SIM 
imaging. Our results provide new insights into host-microbe interactions, supporting that 
MalaEx may have a role in the sensitization and maintenance of inflammation in AE by 
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Gelatin is produced by hydrolysis from collagen, the most prominent extracellular matrix 
protein. Therefore, gelatin can be presents chemical composition that and biochemical 
properties that are well suited for designing artificial extracellular matrices (ECM). We have 
developed a strategy where glucose is added to achieve additional crosslinking during thermal 
treatment, resulting a biocompatible material that preserves its nanoscale morphology in wet 
state. It has been demonstrated in recent studies that the 3D surroundings its local mechanical 
properties also play a critical part in directing cell decisions. Hereby we report the results of 
several material design approaches to 3D arrangements of fibrous glucose-crosslinked gelatin. 
Electrospinning was used to produce gelatin nanofibers. Obtained material was processed into 
a suspension of short fibers, which was thereafter used to prepare fibrous sponges. Other porous 
gelatin materials were prepared by immersion precipitation and an alternative spinning method. 
Obtained scaffolds were subject to cell culture studies using human dermal fibroblasts and 
Hepg2, mass spectroscopy, fluorescence microscopy, SEM and mechanical characterization.  
While strong cell-material interactions were observed on all gelatin scaffolds, superior cell 
penetration into deper layers of the material. Ongoing work is dedicated to developing a ECM 
platform for developing tissue equivalents and disease models 
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Nuclear factor kappa-B (NF-κB ) is a transcriptional factor involved in the modulation of 
immune response, cell proliferation and apoptosis in various cells types, including those of the 
endometrium. It controls the synthesis of proinflammatory cytokines regulating reproductive 
processes. The present study aimed to evaluate the effect of peroxisome proliferator-activated 
receptor (PPAR) ligands on NF-κB gene and protein expression in the endometrium of sows, 
depending on their reproductive status. 
Porcine endometrial slices, collected at days 14-16 of the estrous cycle (late-luteal phase; n=5) 
or pregnancy (beginning of implantation; n=5), were incubated in vitro for 6 h in the presence 
of PPARα (agonist WY 14643 and antagonist MK-886), PPARβ (agonist L-165,041 and 
antagonist GW9662) or PPARγ (agonists: 15d-prostaglandin J2 (PGJ2) or rosiglitazone and 
antagonist T0070907) ligands. The mRNA and protein levels in the tissue were determined by 
Real Time PCR and Western Blot, respectively. The effect of the treatment was determined by 
one-way analysis of variance followed by the Duncan post hoc test. 
During the estrous cycle, the agonists of three PPAR isoforms (alfa, beta and gamma) 
diminished NF-κB mRNA expression in the porcine endometrium. In addition, the inhibitory 
effect of PPARβ and PPARγ (but not PPARα) agonists on NF-κB protein level was noted. 
During pregnancy, the agonists of PPARα and PPARβ (but not PPARγ) reduced the expression 
of NF-κB mRNA, whereas the tested compounds did not affect the protein level.  
The obtained results imply the involvement of PPARs in the expression of NF-κB in the porcine 
endometrium. They indicate a diverse receptivity of the tissue to the PPAR ligands, depending 
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on the reproductive stage of sows. The impact of the ligands on NF-κB gene and protein 
expression in the endometrium is relevant during the estrous cycle what may suggest that 
PPARs, as anti-inflammatory factors, modulate the immune system during luteolysis. 
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Preparation of endometrium to embryo implantation is a crucial process controlled by many 
factors including great number of cytokines. Chemokines (small proteins belonging to 
cytokines family) are known mainly because of their role in chemoatraction of immune cells to 
inflammation site. Nowadays, still new important role of these proteins in different cell types 
is being discovered. 
The aim of our study was to identify chemokine/-s which can contribute to preparation of 
epithelial cells for proper embryo implantation. 
Endometrial epithelial cells were obtained using enzymatic digestion of tissue from mature 
gilts. After purification, cells were cultured to reach 70% confluence and then treated with 
recombinant chemokines in physiological concentration (1ng/ml). Proliferation analysis was 
performed using colorimetric Cell Proliferation Assay. Cells ability to adhesion was examined 
using Crystal Violet staining. Gene expression was measured by real-time PCR. All data were 
statistically analyzed with 1-way ANOVA followed by NIR Fisher test. 
Analysis of gene expression disclose presence of transcript for all examined chemokines’ 
receptors in epithelium, with the highest expression of CXCR4 (receptor for SDF1). All 
chemokines significantly (p<0.001) enhanced epithelial cell proliferation. Adhesion assay 
revealed only SDF1- positive effect and CCL8- negative effect on cell adhesion in comparison 
to control group. Expression on mRNA for Muc-1 coincide with adhesion results, indicating 
inhibitory effect of SDF1 on Muc-1 expression. Downregulation of Muc-1 was also observed 




In conclusion, our results show that some of chemokines may affect functions of epithelial cells. 
Especially, SDF1 with positive effect on cells proliferation and adhesion, may be the one of 
crucial factors contributing to appropriate embryo implantation in non-invasive type of 
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Previously, we reported an air-liquid interface approach to culture oviductal epithelial cells, 
which recapitulated polarization and ciliogenesis of oviduct epithelia in vivo and allows long-
term cultivation as well as estrous cycle simulation. Prostaglandins are known to participate in 
embryo development and transport; however, the hormonal regulation of their synthesis 
remains unclear. Thus, aim of this study was to investigate the expression of key enzymes of 
the prostaglandin synthesis pathway during in vitro simulation of estrous cycle stages in ALI-
POEC. 
We sequentially simulated diestrus and estrus stages in ALI-POEC using serum levels of 
estradiol (E2) and progesterone (P4) either in combination (mix group) or separately (P4 and 
E2 group). The control group received solvent only. Gene expression was measured by RT-
qPCR, while localization of proteins was determined by immunofluorescence.  
In the mix group, gene expression of mPGES-1 was significantly higher in diestrus than in 
estrus. In the separate simulations, P4 caused up- and E2 down- regulation of mPGES-1 
expression. Expression of PGFS was increased in estrus in comparison to diestrus in all groups. 
No differences in PTGS2 and PGIS expression were revealed. PGIS and mPGES-1 proteins 
were localized in cytoplasm of all, whereas PGFS and PTGS2 were present in cytoplasm and 
membranes of individual cells. CBR1 protein was specifically observed in the apical parts of 
the epithelial cells.  
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In conclusion, taking advantage of the polarized ALI-POEC system, this preliminary study 
provided evidence for the regulation of the prostaglandin synthesis pathway by E2 and P4 in 
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MSCs have an intriguing property of in vitro self-assembly into three-dimensional (3D) 
aggregates. Recent studies have shown that MSC 3D aggregation enhances a range of biological 
functions, such as proliferation, potential for multilineage differentiation, secretion of 
therapeutic factors, immunomodulation, anti-tumour properties thus leading to improved 
therapeutic potential.  
Adipose tissue derived MSCs cultured in hanging drops formed a loose network of grouped 
cells at day 1. At day 2 the numerous small aggregates shrank and formed a single compact 
structure. These structures were fixed and the prestained with CFSE (cytoplasm) and Hoechst 
(nuclei) MSCs in the spheroids were analyzed by confocal imaging. The result revealed that the 
cell number is inversely proportional to the size of the formation. The smallest structures were 
formed from 21000 cells and reached the size of 480+/- 50 µm, and the biggest spheroids 
contained 10000 cells and were 675+/- 30 µm in size. The confocal imaging revealed non-
homogeneous structures, consisting of cells with different shape and dimensions and a lot of 
cavities. The cells in the spheroid surface were smaller than those in the inner part. In the course 
of time the spheroids grew (480 +/-50 µm at day 2; 700 +/-20 µm at day 3, and 750 +/-60 µm 
at day 6), became more compact and reduced the cavities by day 6. Our data showed that almost 
all MSCs in the spheroids are alive (Fixable Viability Dye eFluor 450) and proliferating. In the 
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Progesterone (P4) affects cells function by genomic mechanism through nuclear P4 receptors, 
and via nongenomic mechanism through the membrane P4 receptors, such as: progesterone 
receptor membrane component (PGRMC) 1 and 2 and membrane progestin receptors (mPR) 
alpha (mPRα), beta (mPRβ) and gamma (mPRγ). The presence of membrane P4 receptors has 
also been demonstrated in human JEG-3 choriocarcinoma cells though the mechanism that 
regulate the expression of membrane P4 receptors are unknown. It should be emphasized the 
cell line JEG-3 is a reliable and used model for studying the secretory function of placental 
trophoblast and the participations of receptors in these processes. Therefore, the aim of study 
was to examine the effect of chorionic gonadotropin (hCG; 10ng/ml), P4 (10-5M), estradiol 
(E2; 10-9M) and 5% amniotic fluid (AF) on gene expression for: PGRMC1, PGRMC2, mPRα, 
β and γ in cell line JEG3 (1,2x105/ml). After 6 (n=4) and 24h (n=6), the concentration of P4 
and E2 in medium and mRNA expression of studied genes were determined by an enzyme-
immunoassay (EIA) and Real Time PCR method, respectively. 
Obtained data indicate, that P4 and AF increased concentrations of E2 in medium (p<0.05) after 
6 and 24h. Moreover, P4 stimulated (p<0.05) expression of mPRγ and PGRMC2 while AF 
decreased (p<0.05) expression of mPRβ after 6h of incubation. These results suggest that 
steroids and amniotic fluid may regulate secretory function and expression of mPRβ, mPRγ and 
PGRMC2 mRNA in cell line JEG-3. 
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We found the variable expression of mRNA and protein for progesterone receptor membrane 
component (PGRMC) 1 and 2, PGRMC1 binding partner – SERBP1 (serpine 1 mRNA binding 
protein) and membrane progestin receptors (mPR) α, β and γ in bovine myometrium during the 
estrous cycle but the regulatory mechanism of mRNA expression of these receptors in 
myometrium is not clear. The aim of the present study was to examine the effect of P4 (10-
7;10-6;10-5M), estradiol (E2; 10-10;10-9;10-8 M), P4 (10-6M or 10-5M) together with E2 (10-
9M or 10-8M) and arachidonic acid (AA;10-5M as positive control) on gene expression for: 
PGRMC1, PGRMC2, SERBP1, mPRα, β and γ in the bovine myometrial cells (2.5x105/ml; 
n=5) from days 6-10 and 11-16 of the estrous cycle. After 6h, the concentration of PGF2 and 
PGE2 in medium and mRNA expression of studied genes were determined by EIA and Real 
Time PCR. Obtained data indicate that E2 (10-8M) stimulated (P<0.05) expression of 
PGRMC1 mRNA, and P4 (10-5M) and P4 together with E2 increased (P<0.05) mPRβ mRNA 
in the cells from 6-10 days of the estrous cycle. In the cells from 11-16 days of the estrous cycle, 
P4 (10-6 M) and E2 (10-10M) decreased (P<0.05) only SERBP1 mRNA, but P4 in the dose of 
10-5M increased (P<0.05) the expression of this gene. These results suggest that steroids may 
regulate PGRMC1, SERBP1 and mPRβ mRNA expression in the bovine myometrial cells and 
this effect depends on the days of estrous cycle and steroids dose. 
Supported by Grant NCN 2012/05/B/NZ4/01810 and by Polish Academy of Sciences. 
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Rotating bioreactors on a clinostat system create an environment that allows bone cells to 
aggregate into 3D multicellular spheroids and form bone-tissue like structures 1,2. These 3D 
in vitro analogs of human bone represent a new potential model for testing of various stimuli 
on bone formation and remodeling 2. The active vitamin D metabolite 1,25(OH)2D has a 
known function in bone homeostasis. Vitamin K2 is a cofactor of gamma-carboxylase, and 
essential for the pathway of gamma-carboxylation of osteocalcin (OC) 3. Studies showed a 
stimulating effect of a combined administration of vitamin D3 and K2 on osteoblast 
mineralization 4,5 and bone mineral density in vivo 6,7.  
In this study, the effect of vitamin K2 alone and in combination with vitamin D3 is tested in 
two different rotary culture systems in the 3D bone model. Results are compared to each other 
and to effects in a 2D culture system.  
3D mineralized bone constructs were generated either in the rotary cell culture system 
(RCCS) (Synthecon, Inc., Houston, TX) or the BioArray Matrix drive BAM v4 (CelVivo, 
Blommenslyst, Denmark) with human primary osteoblasts (hOBs) and osteoclast precursor 
cells. Vitamin D3 and K2 (both MK-4 and MK-7), alone and in combination, were 
administrated. Untreated cells were used as control. After 21 days, osteospheres were 
characterized in terms of mineralization by Alizarin Red S staining, Alkaline Phosphatase 
activity and expression of collagen type I. The secretion of cytokines and bone factors to the 
medium was analyzed by Luminex.  
In a 2D culture system, the secretion of OC from hOBs was highest by a combined treatment 
of vitamin K2 form MK-4 (10 µM) and vitamin D3 (10-8 M). In the 3D bone model, vitamin 
treatment distinctly reduced osteosphere stiffness compared to the untreated control.  
Ex vivo-derived 3D bone constructs may be utilized in physiological studies of bone 
formation, remodeling and function.  
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